A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

Publication | Closed Access

DOI

Citations

References

2012

Year

Katsuya Harada, Kazuhiro Nakato, Junko Yarimizu, Mayako Yamazaki, Masahiko Morita, Shinji Takahashi, Masaki Aota, Kyoko Saita, Hitoshi Doihara, Yuichiro Sato,

European Journal of Pharmacology

Alzheimer's DiseaseMedicineCognitive DysfunctionPsychotropic MedicationAnimal ModelsNeuropharmacologyNeurochemical BiomarkersNeuroscienceNeurologyBiological PsychiatryMolecular NeurobiologyBrain PathologyPharmacologyNeurochemistryNovel Glycine Transporter-1